Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors-Reference-Cited by-同舟云学术

Discovery of novel hydroxyamidine based indoleamine 2,3-dioxygenase 1 (IDO1) and thioredoxin reductase 1 (TrxR1) dual inhibitors

Published:2023-01 Issue: Volume:245 Page:114860
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Zhou Ji,Yu Li-Zhen,Fan Ya-Li,Guo Ci-Hao,Lv Xiao-Mei,Zhou Zhi-Yin,Huang Hui-Dan,Miao Dong-Dong,Zhang Sheng-Peng,Li Xin-Yu,Zhao Ping-Ping,Liu Xiao-Ping,Hu Wei-Hua,Zhang Chao^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference50 articles.

1. Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?;Feng;Cancer Commun.,2019

2. Microbiota, inflammation and colorectal cancer;Lucas;Int. J. Mol. Sci.,2017

3. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade;Le;Science,2017

4. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study;Overman;Lancet Oncol.,2017

5. The role of oxidative stress and its counteractive utility in colorectal cancer (CRC);Basak;Cancers,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases;Redox Biology;2024-04

2. Fluorescent Probes for Mammalian Thioredoxin Reductase: Mechanistic Analysis, Construction Strategies, and Future Perspectives;Biosensors;2023-08-13

3. Research progress of STAT3-based dual inhibitors for cancer therapy;Bioorganic & Medicinal Chemistry;2023-08

4. Prediction of IDO1 Inhibitors by a Fingerprint‐Based Stacking Ensemble Model Named IDO1Stack;ChemMedChem;2023-06-30